查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1624399

軟骨修復-軟骨再生全球市場規模（按應用、治療方式、地區、範圍和預測）

Global Cartilage Repair-Cartilage Regeneration Market Size By Application, By Treatment Modality, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

軟骨修復 - 軟骨再生的市場規模與預測

2019 年軟骨修復 - 軟骨再生市場規模價值 6.0065 億美元，預計到 2027 年將達到 15.3569 億美元，2020 年至 2027 年的複合年增長率為 13.43%。

預計未來幾年骨關節炎等骨骼和關節疾病的增加、運動傷害的增加以及軟骨再生技術的進步將推動軟骨修復再生市場的發展。軟骨修復-軟骨再生全球市場報告對市場進行了全面的評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

定義全球軟骨修復-軟骨再生市場

軟骨修復 - 軟骨再生是一種關節治療，可以使軟骨恢復健康但受損。軟骨可能因受傷而受損，促使功能障礙和疼痛。缺乏血液供應是軟骨損傷的原因之一。

透過早期採用軟骨修復或再生方法可以預防骨關節炎的發展。依應用不同，分為軟骨修復與再生、纖維軟骨修復與再生。有許多類型的治療方法，包括基於細胞的方法、軟骨細胞移植、生長因子技術、幹細胞、非基於細胞的方法、組織支架和無細胞複合材料。

軟骨修復 – 軟骨再生的全球市場概況

預計骨關節炎等骨骼和關節疾病盛行率的上升以及軟骨再生技術的進步將在未來幾年推動軟骨修復再生市場的發展。此外，老年人口的增加和運動傷害數量的增加預計將在未來幾年推動市場的發展。此外，預計在預測期內糖尿病盛行率的上升將推動市場的發展。也有一些因素和課題阻礙了市場成長。不利的報銷情況和治療費用上升等因素可能會對市場產生限製作用。

目錄

第 1 章 軟骨修復與再生：全球市場介紹

    市場概況
  • 研究範圍
  • 先決條件

第 2 章執行摘要

第 3 章：經過驗證的市場研究方法

  • 資料探勘
  • 驗證
  • 主要來源
  • 資料來源列表

第4章 全球軟骨修復-軟骨再生市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 阻礙因素
    • 機會
  • 波特五力模型
  • 價值鏈分析
  • 監理框架

第 5 章軟骨修復 - 軟骨再生全球市場（按應用）
  • 概述
  • 透明質酸軟骨修復與再生
  • 纖維軟骨修復與再生

第6章 全球軟骨修復與再生市場（依治療方式劃分）

  • 概述
  • 基於細胞的方法
  • 軟骨細胞移植 生長因子技術
  • 幹細胞
  • 非基於細胞的方法
  • 組織支架
  • 無細胞複合材料

第 7 章軟骨修復-軟骨再生全球市場（按區域）
  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
    亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區
    • 拉丁美洲
    • 中東和非洲

第 8 章全球軟骨修復-軟骨再生市場：競爭格局

  • 概述
  • 公司市佔率
  • 供應商概況
  • 主要發展策略

第9章 公司簡介

  • Zimmer Biomet Holdings, Inc.
  • DepuySynthes（Johnson & Johnson Company）
  • Vericel Corporation
  • Smith & Nephew PLC
  • Osiris Therapeutics, Inc.
  • Arthrex, Inc.
  • RTI Surgical
  • ConmedLinvatec
  • LAnika Therapeutics S. R. L.
  • B. Braun Melsungen AG

第10章 附錄

  • 相關調查
簡介目錄
Product Code: 24169

Cartilage Repair-Cartilage Regeneration Market Size And Forecast

Cartilage Repair-Cartilage Regeneration Market size was valued at USD 600.65 Million in 2019 and is projected to reachUSD 1535.69 Million by 2027, growing at aCAGR of 13.43% from 2020 to 2027.

The rising incidences of bone & joint disorders like osteoarthritis, the growing number of sports injuries, and technological advancements in cartilage regeneration are expected to drive the Cartilage Repair-Cartilage Regeneration Market over the predicted years. The Global Cartilage Repair-Cartilage Regeneration Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cartilage Repair-Cartilage Regeneration Market Definition

Cartilage Repair-Cartilage Regeneration Is a Joint Treatment for Having Healthy but Damaged Cartilage. the Cartilage Gets Damaged Due to Injury-Causing Impaired Function and Pain. a Direct Blow, Progressive Degeneration, and Traumatic Injury Are Some of The Reasons for Articular Cartilage Injuries. the Progressive Loss of Structure and Function of The Cartilage Causes Degeneration of Cartilage. Lack of Blood Supply Is One of The Reasons for Cartilage Damage.

Development of Osteoarthritis Can Be Prevented by Early Adoption of Cartilage Restoration or Regeneration Methods. Based on The Application, the Market Can Be Classified Into Hyaline Cartilage Repair and Regeneration and Fibrocartilage Repair and Regeneration. Various Types of Treatment Modalities Are Cell-Based Approaches, Chondrocyte Transplantation, Growth Factor Technology, Stem Cells, Non-Cell-Based Approaches, Tissue Scaffolds, and Cell-Free Composites.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Cartilage Repair-Cartilage Regeneration Market Overview

The rising incidences of bone & joint disorders like osteoarthritis and technological advancements in cartilage regeneration are expected to drive the Cartilage Repair-Cartilage Regeneration Market over the predicted years. Also, the increasing geriatric population and the growing number of sports injuries expect a boost to the market in the coming years. Additionally, the growing prevalence of diabetes is predicted to fuel the market during the forecasted period. There are certain restraints and challenges faced which can hinder market growth. Factors such as unfavorable reimbursement scenarios and higher costs of therapy are likely to act as market restraints.

Global Cartilage Repair-Cartilage Regeneration Market: Segmentation Analysis

The Global Cartilage Repair-Cartilage Regeneration Market is Segmented on the basis of Application, Treatment Modality, And Geography.

Cartilage Repair-Cartilage Regeneration Market, By Application

  • Hyaline Cartilage Repair and Regeneration
  • Fibrocartilage Repair and Regeneration

Based on Application, the market is bifurcated into Hyaline Cartilage Repair and Regeneration and Fibrocartilage Repair and Regeneration. The Hyaline Cartilage Repair and Regeneration segment is expected to hold the largest market share. The factors can be attributed to the increasing incidents of physical trauma all over the world.

Cartilage Repair-Cartilage Regeneration Market, By Treatment Modality

  • Cell-Based Approaches
  • Chondrocyte Transplantation
  • Growth Factor Technology
  • Stem Cells
  • Non-Cell-Based Approaches
  • Tissue Scaffolds
  • Cell-Free Composites

Based on Treatment Modality, the market is bifurcated into Cell-Based Approaches, Chondrocyte Transplantation, Growth Factor Technology, Stem Cells, Non-Cell-Based Approaches, Tissue Scaffolds, and Cell-Free Composites. Cell-Based Approaches are predicted to hold the most significant CAGR in the forecasted period due to the technological advancements in stem cell-based therapies for cartilage repair and chondrocyte implantation products.

Cartilage Repair-Cartilage Regeneration Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on regional analysis, the Global Cartilage Repair-Cartilage Regeneration Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share in the market will be dominated by the Asia Pacific owing to the rise in incidences of various disorders & injuries and the increasing geriatric population in this region.

Key Players

  • The "Global Cartilage Repair-Cartilage Regeneration Market " study report will provide valuable insight with an emphasis on the global market. The major players in the market Such As
  • Zimmer Biomet Holdings, Inc., DepuySynthes (Johnson & Johnson Company), Vericel Corporation, Smith & Nephew PLC, Osiris Therapeutics, Inc., Arthrex, Inc., RTI Surgical, ConmedLinvatec, Anika Therapeutics S. R. L., B. Braun Melsungen AG.
  • These Major Players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET, BY APPLICATION

  • 5.1 Overview
  • 5.2 Hyaline Cartilage Repair and Regeneration
  • 5.3 Fibrocartilage Repair and Regeneration

6 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY

  • 6.1 Overview
  • 6.2 Cell-Based Approaches
  • 6.3 Chondrocyte Transplantation
  • 6.4 Growth Factor Technology
  • 6.5 Stem Cells
  • 6.6 Non-Cell-Based Approaches
  • 6.7 Tissue Scaffolds
  • 6.8 Cell-Free Composites

7 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Share
  • 8.3 Vendor Landscape
  • 8.4 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Zimmer Biomet Holdings, Inc.
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 DepuySynthes (Johnson & Johnson Company)
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Vericel Corporation
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Smith & Nephew PLC
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Osiris Therapeutics, Inc.
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Arthrex, Inc.
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 RTI Surgical
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 ConmedLinvatec
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 LAnika Therapeutics S. R. L.
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 B. Braun Melsungen AG
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Appendix

  • 10.1 Related Research